Literature DB >> 2777105

Plasma exchange in the therapy of Behçet's disease.

M B Raizman1, C S Foster.   

Abstract

Present therapies for Behçet's disease are unsatisfactory in many cases. We investigated the role of plasma exchange in four patients with severe Behçet's retinitis who were unresponsive to standard medical therapies. Plasma exchange induced a rapid reduction of ocular inflammation with improved visual acuity in all cases. In patients with severe Behçet's retinitis, plasma exchange is able to interrupt the acute inflammatory activity, but relapses may occur.

Entities:  

Mesh：

Year:  1989        PMID： 2777105     DOI： 10.1007/BF02169413

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


  16 in total

Review 1.  Behçet's disease. Report of 41 cases and a review of the literature.

Authors:  T Chajek; M Fainaru
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889

2.  Polymorphonuclear leucocyte function in Behçet's disease.

Authors:  J D Sobel; S Haim; N Obedeanu; T Meshulam; D Merzbach
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

3.  Leucocyte movement and colchicine treatment in Behcet's disease.

Authors:  N Matsumura; Y Mizushima
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

4.  Neurologic involvement in seven patients with Behçet's disease.

Authors:  J D O'Duffy; N P Goldstein
Journal:  Am J Med       Date:  1976-08       Impact factor: 4.965

Review 5.  Behçet's disease.

Authors:  J B Michelson; F V Chisari
Journal:  Surv Ophthalmol       Date:  1982 Jan-Feb       Impact factor: 6.048

6.  Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy.

Authors:  J L Jorizzo; R D Hudson; F C Schmalstieg; J C Daniels; P Apisarnthanarax; J C Henry; E B Gonzalez; Y Ichikawa; T Cavallo
Journal:  J Am Acad Dermatol       Date:  1984-02       Impact factor: 11.527

7.  Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease.

Authors:  J D O'Duffy; D M Robertson; N P Goldstein
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

8.  Therapeutic effects of short-term plasma exchange in endogenous uveitis.

Authors:  A J Wizemann; V Wizemann
Journal:  Am J Ophthalmol       Date:  1984-05       Impact factor: 5.258

9.  The mechanism of hyperchemotaxis in Behçet's disease.

Authors:  A Takeuchi; K Kobayashi; M Mori; Y Mizushima
Journal:  J Rheumatol       Date:  1981 Jan-Feb       Impact factor: 4.666

10.  [Plasma exchange and acyclovir in Behçet's disease].

Authors:  M Bonnet; D Ouzan; C Trepo
Journal:  J Fr Ophtalmol       Date:  1986       Impact factor: 0.818
View more
  2 in total

Review 1.  Therapeutic apheresis in autoimmune diseases.

Authors:  Rolf Bambauer; Reinhard Latza; Carolin Bambauer; Daniel Burgard; Ralf Schiel
Journal:  Open Access Rheumatol       Date:  2013-11-13

2.  Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity.

Authors:  Tamer Kahraman; Gozde Gucluler; Ismail Simsek; Fuat Cem Yagci; Muzaffer Yildirim; Can Ozen; Ayhan Dinc; Mayda Gursel; Lolai Ikromzoda; Tolga Sutlu; Stephen Gay; Ihsan Gursel
Journal:  J Extracell Vesicles       Date:  2017-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.